Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
COURT FEES - Well hot damn blue skies
You've been beating the drum for reimbursements and a judge agrees. Awarding "us" $1,012,527.67.
Maybe more importantly this will get EMED to bail out if the one remaining case.
i haven't. I also haven't been able to verify the price target being upped to $6.
Attorney fees and court costs.
I finally had a chance to read the conference call and noticed KORU quantified the court costs and attorney fees. Looks like they are trying to claw back over $3 million.
"While litigation continues, the company has recently announced two favorable court rulings and is pursuing recovery of court costs on attorney's fees, that in aggregate total approximately $3.4 million for these two closed cases."
Also, KORU will be presenting at the Craig Hallum, Alpha Select Conference tomorrow.
A poster on my micro cap club posted that Craig-Hallum
has upped their price target to $6. It was posted 5 hours ago, so during the trading day - no positive impact.
This was just someone's post with no link etc. However, I trust anything posted on this website. Will provide link when/if available.
Management basically said his (Nowak's) revenue estimate for Q4 was in the ballpark or something like that. On CH initial report he has Q4 rev stimate of $5.5 million. that would put us at $22 million for the year. His price target is $5.50 I would expect a report out shortly with an update and hopefully arevised PT.
If not for the legal fees I think we would have been at 4-5 cent profit for the quarter.
My biggest takeaway from the call is the more apparent push of the European growth opportunity. "2-3x larger than US."
I have to listen to the call again as I was distracted during the call.
As always I will monitor the weekly closing price. With the massive volume this week the closing level will be important. The 10 week moving average is $3.93.
Sounds like $900,000 or so of the revenue was a one off so really like $5.7 million in revenues for the quarter per CC.
So not as bullish as the initial headline.
Stock Market Mechanics
Everything is in place for an explosive upside move. Low tradeable float, earnings, revenue, and business momentum coupled with the uplisting.
Massive volume already this week with plenty more to follow.
I am assuming the new European buyer is Grifols??
Hell Yes !! $6.6 million revenues
Q3 2019 Highlights
Net sales rose 45.5% to a record $6.6 million
Gross margin improved to 66.2%
Operating profit increased 70.8% to $0.8 million
Net income rose to $0.7 million, or $0.02 per diluted share
Adjusted EBITDA up 88.8% to $2.1 million
If earnings are good we will get momentum buyers as the stock trades through 4.25 for a new 52 week high.
The consolidation is from 3.30-4.25 - I'd say, technically speaking - $5.20 is a reasonable short term target. I think today was the highest volume day of the year.
We can see $5 in short order. Of course all comes down to ER and CC.
Looking forward to the numbers and conference call.
Not hppy with it closing on low of day on big volume. Let's see where we closecend of week.
Let's get a close above $4 for the week.
Stock continues to hug the 10 week moving average.
Drifted lower on reduced volume. hopefully today's uptick from the low on increased volume will give us some upward momentum.
All eyes on Tuesday night's earning release and CC on Wednesday.
Earnings Tuesday, Novebmer 5ty after close.
insert-text-here
I'll speculate because I am a speculator.
The timing of this announcement, before the release of earnings, would lead me to believe the earnings should be very good. There may also be some other positive headline, as you alluded to - new product etc.
Why announce the new name prior to earnings if they are going to disappoint? I am sure they want the new name associated with positive developments.
With that said the seller is back and stock under pressure again.
Rebranding ??? I guess they've been busy with more than the uplist.
New Ticker Symbol “KRMD”
CHESTER, N.Y.--(BUSINESS WIRE)-- Repro Med Systems, Inc. (NASDAQ: REPR) (“the Company”) today announced a new dba name, KORU Medical Systems, which the Company will begin using in place of RMS Medical Products on October 24, 2019. Reflecting this change, the Company’s common stock will commence trading under the new ticker symbol “KRMD” on the NASDAQ effective October 24, 2019.
Earnings Announcement
According to CNBC website earnings are due to be reported today after market close.
I am not sure that’s accurate but it is on CNBC website.
@blue skies
Chris on the yahoo board is me - hahaha
agree that it is worth listening to opinions that may differ.
I am still holding my full position. I would like to lighten on any jump to new highs. That's just because I am overweight REPR right now.
I was hoping the uplisting would bring a bigger rally into new highs. Perhaps that will come rest of week. Otherwise all eyes on next earnings report and I'd expect Craig Hallum analyst to check in again post entry to Nasdaq.
It looked like a seller(s) came in with about 20,000 shares to go. buyers marked the closing up. I'd much prefer some tighter action.
Do you have any concerns on valuation? Trading >7X trailing 12 month revenues? This point was brought up on Yahoo board and worth considering. The Craig Hallum $5.50 price target is at 8X his 2020 revenue est. of $2.4 million.
Company set the proper expectation, per upliast, and delivered again pretty much on schedule-a strong suit of the company that you pointed out. Hopefully we can get some upside pressure and test/make new highs this week.
Do we know the earnings release date? I see we released third quarter earnings 10/23 last year.
Uplisting
From the September 9th Craig-Hallum report "Management reiterated it has filed all necessary paperwork and should hear back from Nasdaq in the coming weeks."
We could use a good catalyst for a price jump.
we'll see. definitely under pressure and not unusual given the large run up. Never know when the seller will be cleaned up. Large buyer stepped in today and was able to buy 40,000 shares or so on the bid at 3.40.
Let's see if we get another large buyer tomorrow at higher prices.
For the better part of my trading life I was a day trader, in fact, I was a day trader before that term even existed. The real money is made investing yet I still have to fight the old mentality of a day trader.
Still think the weekly moving avg is a key. If we can close $3.55 plus tomorrow and stabilize from there I'd be happy.
Breaking the 10 week moving average (3.63) is concerning to me. Hopefully we can get a rally by end of week and close above that level.
No buyers and no bounce for a couple weeks now. Color me concerned.
Was hoping for new highs this week. Slightly disappointed. I am watching and hoping that the 10 week moving average holds.
Company Presentation
REPR will be presenting at the Micro Cap Club Leadership Summit on Friday. Not sure if it’s morning or
Afternoon session
https://microcapclub.com/summit/
Technically Speaking
The recent low volume pull back may have concluded yesterday with a test of the 10 week moving average ($3.51) and 1 day reversal to close on 10 day MA ($4). This is the exact type of action we want to see when the stock nears the 10 week MA. Large buyer(s) stepped up.
I expect new highs in the next week or two.
I like the outside the US opportunity. That looks like a solid opportunity for significant growth.
Uplisting - I have seen some speculate that September 10th is a timeframe for potential uplisting - something to do with trading 90 days over $2.
I am waiting for that headline and hope to lighten my position into that strength. My position here is very large, just looking to pull some risk off.
I lik e he risk section as I think all, but the litigation, can be discounted, at this point. The activist shareholders must be tickled pink.
We even have momentum on the litigation.
If you copy/paste that link it should work.
Craig Hallum Update From Yesterday
file:///C:/Users/csiri/AppData/Local/Packages/Microsoft.MicrosoftEdge_8wekyb3d8bbwe/TempState/Downloads/REPR%20-%20Craig%20Hallum%209-9-19%20(1).pdf
Blue Skies
Where was that mention of government contracts?
Thank you for that. That puts, theoretically, the available shares below 20,000,000 by my estimation. Of course everyone has a price.
Today's Action
I think you may continue to see bull runs, like todays, on REPR given the current share allotment. These numbers are not meant to be exact, just to show how low the float is. Uplisting the next potential catalyst to draw buyers.
REPR has 38 million shares in the float - MANKO owns 12 million, various insiders own an additional 2 million. That number may be higher but I am lazy and whatever more exact number I find will have no impact on my position.
So you have a stock of about a 25 million (maybe less) float with one analyst covering - whose clients loaded up around $2-$2.50 and maybe higher. You have Manko with his huge position. I don't think he bought 12 million shares of this stock to try and get out at $4 or even $6.
He is likely looking for a lot more.
You have the Craig Hallum clientele who are likely not looking to sell as, just like me, the story is one that is easy to understand and is playing out perfectly.
New Management
"New" product in the sense that the marketplace is moving right towards REPR.
Run this through CANSLIM and you go 7 for 7 in my opinion. One could argue the C for current quarterly earnings is not their yet but they are moving in right direction per revenues. And the 60-70% margins will produce profit sooner rather than later.
Idk about getting reimbursed legal fees.
I am more interested in seeing an updated report from Craig Hallum after they meet with the company. Hopefully REPR gives an update on Hizentra numbers and some indication on expectations for Xemblify.
I suspect the analyst is itching to up his price target (from $5.50) but will need some ammo to justify it
Craig Hallam note this morning.
Interesting note on meeting with company this week. I copy/pasted this from a micro cap club I belong to.
EPR* – The Southern District of New York Court announced on Friday that RMS won its lawsuit vs. EMED and dismissed the case. Alex Nowak notes there were three original lawsuits under old management in Texas, California and New York. The Texas case was resolved June 27th, New York was resolved Friday and California remains the final outstanding case. In particular, the NY case drove the majority of the legal spend, which amounted to $1.6M in 1H19. Alex points out legal spend should decline 2H19 with the dismissal, which is important as REPR only has $4M in cash. Craig-Hallum will be hosting management meetings in Minneapolis tomorrow and will be listening for an update on the legal efforts + business progress with Hizentra and Xembify. Alex rates REPR shares a Buy.
Damn, Dude, you’re quick.
Correction
that's $3.10 on the 10 day moving average
The one day reversal sets up the first technical negative in months. It’s on my mind but it was not on big volume which is good.
I am very focused on the 10 week moving avg which is right at $3. Important to stay above that.
The stock has definitely changed character here the last few trading days.
The uplisting will be uplifting ;)
I prefer the slow grinding action on way up.
Hopefully we can close $3.55 plus for the week.
I have to be careful getting too wrapped up in the daily stock action.
This is a 300 million dollar company, at least, trading at 150 million or so. That’s what I need to keep on mind.
Technically
Stock looks ready to move above recent highs. Could jump to $3.60-3.76 short term.